UPDATE : Thursday, October 17, 2019
상단여백
Seoul Medical Center transfer public healthcare know-how to developing countries
Seoul Medical Center (SMC) is speeding up the transfer of "Seoul-model publ...
by Lee Han-soo  |  2019-10-15 18:02
라인
‘Genome analysis-based therapy to help realize precision medicine’
Samsung Medical Center has become the world’s first hospital to demonstrate...
by Lee Han-soo  |  2019-10-15 17:50
라인
Kolon Life Science shares surge after TissueGene’s survival
Shares of Kolon Life Science shot up after the regulator decided to delay t...
by Jeong Sae-im  |  2019-10-14 18:01
라인
Lilly’s Taltz shows superiority to Tremfya in treating psoriasis patients
The Korean branch of Eli Lilly said it has presented the phase 4 IXORA-R st...
by Lee Han-soo  |  2019-10-14 18:01
라인
First lung disease reported here with suspected ties to vaping
The Korea Centers for Disease Control and Prevention (KCDC) said that it ha...
by Lee Han-soo  |  2019-10-14 18:01
라인
HLB merges with Elevar to own rivoceranib rights
HLB said it would merge with its subsidiary Elevar, a U.S.-based developer ...
by Jeong Sae-im  |  2019-10-14 14:43
라인
HanAll's Chinese partner ends P2 trial of dry eye treatment
HanAll Biopharma said that Harbour Biomed, its Chinese partner, has complet...
by Lee Han-soo  |  2019-10-14 14:08
라인
[Special] How are Korean employees coping with big-pharma M&As?
Since multinational pharmaceutical companies announced merger and acquisiti...
by Kim Yun-mi  |  2019-10-14 13:45
라인
Sanofi releases data showing improved survival for prostate cancer treatment
Sanofi said that it has published research results confirming a longer radi...
by Lee Han-soo  |  2019-10-14 12:16
라인
Regulator keeps Kolon Tissuegene listed with 1-year grace period
The Korean Exchange (KRX) decided to keep Kolon Tissuegene listed on the Ko...
by Lee Han-soo  |  2019-10-12 09:41
라인
GC to market Merck's diabetes treatment
Merck Biopharma Korea said that GC would market Glucophage, its diabetes tr...
by Lee Han-soo  |  2019-10-11 18:13
라인
Bayer drugs out of stock in Korea
Bayer is having trouble supplying its drug in the local market as the compa...
by Lee Han-soo  |  2019-10-11 16:36
라인
Drug regulator to hire 87 more reviewers next year
The Ministry of Food and Drug Safety said it would add 87 staff for the rev...
by Lee Hye-seon  |  2019-10-11 16:35
라인
Sanofi to cover part of Dupixent cost for atopic dermatitis patients
Sanofi said it would run a program to support part of the cost of Dupixent,...
by Kim Yun-mi  |  2019-10-11 15:13
라인
‘Direct-to-consumer genetic testing needs preparation’
The government has decided to deregulate direct-to-consumer (DTC) genetic t...
by Kim Eun-young  |  2019-10-11 15:12
라인
Takeda Korea’s labor union goes on strike
The conflict between Takeda Korea's management and labor union has reac...
by Lee Han-soo  |  2019-10-11 14:33
라인
Roche’s Tecentriq combo therapy shows encouraging results
Roche Korea said the company had presented results from a phase 1b study ev...
by Lee Han-soo  |  2019-10-10 17:36
라인
Yuyu confirms safety of its antiplatelet drug
Yuyu Pharmaceutical said that it has confirmed the safety of Yuclid (ingred...
by Lee Han-soo  |  2019-10-10 17:35
라인
ICDM 2019 to host 3-day meet in Seoul
The 2019 International Congress of Diabetes and Metabolism will kick off it...
by Lee Han-soo  |  2019-10-10 16:02
라인
Doctors call Boehringer Ingelheim’s Jardiance marketing ‘unethical’
The medical community criticized Boehringer Ingelheim Korea’s recent releas...
by Kim Yun-mi  |  2019-10-10 16:01
여백
여백
여백
Back to Top